Open AccessIdentification of genes modulated in rheumatoid arthritis using complementary DNA microarray analysis of lymphoblastoid B cell lines from disease‐discordant monozygotic twins
Author(s) -
Haas Christian S.,
Creighton Chad J.,
Pi Xiujun,
Maine Ira,
Koch Alisa E.,
Haines G. Kenneth,
Ling Song,
Chinnaiyan Arul M.,
Holoshitz Joseph
Publication year - 2006
Publication title -
arthritis & rheumatism
Language(s) - English
Resource type - Journals
eISSN - 1529-0131
pISSN - 0004-3591
DOI - 10.1002/art.21953
Subject(s) - complementary dna , biology , microarray , microbiology and biotechnology , gene , gene expression , microarray analysis techniques , gene expression profiling , genetics
Abstract Objective To identify disease‐specific gene expression profiles in patients with rheumatoid arthritis (RA), using complementary DNA (cDNA) microarray analyses on lymphoblastoid B cell lines (LCLs) derived from RA‐discordant monozygotic (MZ) twins. Methods The cDNA was prepared from LCLs derived from the peripheral blood of 11 pairs of RA‐discordant MZ twins. The RA twin cDNA was labeled with cy5 fluorescent dye, and the cDNA of the healthy co‐twin was labeled with cy3. To determine relative expression profiles, cDNA from each twin pair was combined and hybridized on 20,000‐element microarray chips. Immunohistochemistry and real‐time polymerase chain reaction were used to detect the expression of selected gene products in synovial tissue from patients with RA compared with patients with osteoarthritis and normal healthy controls. Results In RA twin LCLs compared with healthy co‐twin LCLs, 1,163 transcripts were significantly differentially expressed. Of these, 747 were overexpressed and 416 were underexpressed. Gene ontology analysis revealed many genes known to play a role in apoptosis, angiogenesis, proteolysis, and signaling. The 3 most significantly overexpressed genes were laeverin (a novel enzyme with sequence homology to CD13), 11β‐hydroxysteroid dehydrogenase type 2 (a steroid pathway enzyme), and cysteine‐rich, angiogenic inducer 61 (a known angiogenic factor). The products of these genes, heretofore uncharacterized in RA, were all abundantly expressed in RA synovial tissues. Conclusion Microarray cDNA analysis of peripheral blood–derived LCLs from well‐controlled patient populations is a useful tool to detect RA‐relevant genes and could help in identifying novel therapeutic targets.